MIRM
Mirum Pharmaceuticals Inc
89.30$
-2.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +182.3% | +64.2% | +22.3% | +19.8% | +83.2% | +3.7% | +25.7% | |
| – | +129.7% | +98.0% | -29.5% | +14.2% | +103.7% | +1.4% | +39.9% | |
| – | -77.0% | +1,087.0% | -77.9% | -10.6% | +922.5% | -22.3% | +33.3% | |
| – | +124.5% | +98.7% | -32.5% | -3.1% | +88.7% | -2.1% | +36.7% | |
| – | – | – | – | +449.4% | +183.3% | +15.2% | +57.5% | |
| – | – | – | – | +267.8% | +300.9% | +0.4% | +11.1% | |
| – | – | -65.4% | -24.1% | -6.8% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | +214.6% | +329.0% | -1.2% | +4.4% | |
| – | -73.7% | +320.3% | +153.7% | +20.9% | +88.7% | +11.9% | +18.6% | |
| – | +433.9% | +41.2% | +130.7% | +52.0% | +34.5% | +45.4% | +62.6% | |
| – | – | +60.2% | +11.8% | +30.9% | +18.6% | +54.8% | +25.2% | |
| – | +1,145.7% | -6.0% | +190.9% | -5.2% | -14.7% | +97.1% | -34.2% | |
| – | – | – | – | – | – | +0.5% | +0.6% | |
| – | – | +32.0% | -30.1% | +18.2% | +75.1% | -9.3% | +39.5% | |
| – | – | – | – | – | – | – | – | |
| – | +0.0% | +9.8% | +20.1% | +12.1% | +20.3% | +16.2% | +5.6% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.